InsiderClue
← All stocks

Tenaya Therapeutics, Inc.

TNYA Net buying
CIK 0001858848 #4093 in the set updated 18 Sep 2026
Bought (120 mo)
$161.69M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.39M
$89.00K on a plan · $0.00 straight out of an exercise
Sold at will
$6.30M
72 of 76 sales
Net
+$155.30M
+$155.39M against sales at will

By person

12 insiders · 96 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GOEDDEL DAVID V
Director
$64.56M (8)
—
+$64.56M
54,299,129
$38.54M
—
COLUMN GROUP III GP, LP entity
10% owner
$64.56M (8)
$5.93M (12)
+$58.63M
4,985,570
$3.54M
—
Casdin Eli
Director
$19.23M (2)
—
+$19.23M
6,440,829
$4.57M
+1,679%
Casdin Partners Master Fund, L.P. entity
10% owner
$12.75M (1)
—
+$12.75M
361,969
$256.93K
—
Srivastava Deepak
Director
$600.00K (1)
—
+$600.00K
372,435
$264.35K
+162.9%
Hoey Timothy
Chief Scientific Officer
—
$145.41K (7) scheduled
−$145.41K
245,346
$174.15K
+22.7%
Ali Faraz
Chief Executive Officer
—
$143.72K (19)
−$143.72K
539,782
$383.14K
—
Tingley Whittemore
Chief Medical Officer
—
$107.29K (20)
−$107.29K
263,073
$186.73K
+719.3%
PATTERSON LEONE D
Chief Fin. and Bus. Officer
—
$47.44K (2)
−$47.44K
95,755
$67.97K
+1,671%
Saito Chihiro
SVP, Accounting and Fin. Ops.
—
$11.63K (4)
−$11.63K
60,983
$43.29K
+50.2%
Higa Tomohiro
SVP, Finance
—
$10.89K (12)
−$10.89K
118,267
$83.95K
+15.8%
Kang JeenJoo
Director
—
—
—
25,000
$17.75K
+100.0%

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 79,220,516 to 224,230,012 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
GOEDDEL DAVID V
5 Mar 2025
Director
Buy indirect
35,714,284
$0.70
$25.00M
COLUMN GROUP III GP, LP
5 Mar 2025
10% owner
Buy indirect
35,714,284
$0.70
$25.00M
GOEDDEL DAVID V
12 Feb 2024
Director
Buy indirect
2,222,222
$4.50
$10.00M
COLUMN GROUP III GP, LP
12 Feb 2024
10% owner
Buy indirect
2,222,222
$4.50
$10.00M
GOEDDEL DAVID V
10 Mar 2023
Director
Buy indirect
6,779
$2.60
$17.60K
COLUMN GROUP III GP, LP
10 Mar 2023
10% owner
Buy indirect
6,779
$2.60
$17.60K
GOEDDEL DAVID V
8 Feb 2023
Director
Buy indirect
1,500,000
$2.60
$3.90M
COLUMN GROUP III GP, LP
8 Feb 2023
10% owner
Buy indirect
1,500,000
$2.60
$3.90M
GOEDDEL DAVID V
19 Jan 2023
Director
Buy indirect
69,739
$2.50
$174.20K
COLUMN GROUP III GP, LP
19 Jan 2023
10% owner
Buy indirect
69,739
$2.50
$174.20K
GOEDDEL DAVID V
18 Jan 2023
Director
Buy indirect
135,688
$2.52
$341.43K
COLUMN GROUP III GP, LP
18 Jan 2023
10% owner
Buy indirect
135,688
$2.52
$341.43K
GOEDDEL DAVID V
17 Jan 2023
Director
Buy indirect
49,463
$2.49
$123.40K
COLUMN GROUP III GP, LP
17 Jan 2023
10% owner
Buy indirect
49,463
$2.49
$123.40K
GOEDDEL DAVID V
21 Nov 2022
Director
Buy indirect
9,615,384
$2.60
$25.00M
COLUMN GROUP III GP, LP
21 Nov 2022
10% owner
Buy indirect
9,615,384
$2.60
$25.00M
Srivastava Deepak
21 Nov 2022
Director
Buy indirect
230,769
$2.60
$600.00K
Casdin Eli
17 Nov 2022
Director
Buy indirect
2,492,042
$2.60
$6.48M
Casdin Eli
3 Aug 2021
Director
Buy indirect
850,000
$15.00
$12.75M
Casdin Partners Master Fund, L.P.
3 Aug 2021
10% owner
Buy indirect
850,000
$15.00
$12.75M
Show all 96 transactions →

What was left out

Form 4 filings counted 124
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 0
Sales at will 72
Transactions with no price 0
Shares from compensation/vesting 25,322,084
Sales filed before the plan box existed 1
History held since 4 Aug 2021